Surgical Robotics Technology
HOYA Group has announced the appointment of Rainer Burkard to the position of Global President of PENTAX Medical as of April 1st, 2022.
“HOYA Group is pleased to have Mr. Rainer Burkard lead the global division of PENTAX Medical,” said Eiichiro Ikeda, Representative Executive Officer and CEO of HOYA Corporation. “Mr. Burkard brings a wealth of knowledge, insight and experience from his various global executive roles within HOYA, especially from our PENTAX Lifecare Division. He has a proven track record of delivering results through developing and implementing strategic and operational changes in a global multicultural environment. We expect his leadership to further advance the PENTAX Medical growth strategy”.
Mr. Burkard joined HOYA Lens Deutschland GmbH in 2002 and served as Head of Marketing until 2007. He was then promoted to the HOYA Vision Care global headquarters as General Manager, Business Development. In 2014, he was instrumental in integrating the European operations of SEIKO OPTICAL and led the development of the SEIKO XchangerTM collection which won the prestigious Silmo d’Or award for excellence in optical innovation. He joined PENTAX Europe GmbH as Chief Executive Officer (Europe, Middle East and Africa) in August 2015, and expanded his global role as Chief Commercial Officer of the Americas in July 2020.
“It is an honor taking over the global leadership for our division. I would like to express my sincere gratitude for the leadership provided by Mr. Gerald W. Bottero, PENTAX Medical Global President since 2016. Under his leadership, HOYA corporate values were firmly established and will continue guiding us for the future. We wish Mr. Bottero only the best as he begins his well-earned retirement after 34 years with HOYA”, said Mr. Burkard.
“Moving forward we are going to develop a unified global PENTAX Medical approach to our customers inspired by our Triple Aim. Many of our current and specifically future product innovations will position PENTAX Medical and its solutions uniquely in the market, specifically to and for our customers. This will provide enhanced competitiveness and growth potential while addressing relevant environmental aspects.”
Source: PENTEX Medical.
